Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
Díaz-Rubio E, González-Larriba JL, Rosell R, Abad A, Martín M, Valerdi JJ, Barriga JJ. Díaz-Rubio E, et al. Among authors: martin m. Ann Oncol. 1990 Sep;1(5):379-80. doi: 10.1093/oxfordjournals.annonc.a057780. Ann Oncol. 1990. PMID: 2261379 Free article. Clinical Trial. No abstract available.
The antiemetic efficacy of thiethylperazine and methylprednisolone versus thiethylperazine and placebo in breast cancer patients treated with adjuvant chemotherapy (fluorouracil, doxorubicin and cyclophosphamide). A randomized, double-blind, cross-over trial.
Diaz-Rubio E, Martin M, Rosell R, Valerdi JJ, Gonzalez-Larriba JL, Barriga JJ. Diaz-Rubio E, et al. Among authors: martin m. Acta Oncol. 1991;30(3):339-42. doi: 10.3109/02841869109092382. Acta Oncol. 1991. PMID: 2036244 Clinical Trial.
Ifosfamide in advanced epidermoid head and neck cancer.
Martín M, Diaz-Rubio E, González Larriba JL, Casado A, Sastre J, López-Vega JM, Almenarez J, Dominguez S. Martín M, et al. Cancer Chemother Pharmacol. 1993;31(4):340-2. doi: 10.1007/BF00685683. Cancer Chemother Pharmacol. 1993. PMID: 8422700 Clinical Trial.
LAS 30451: a novel 5-HT3 antagonist.
Martin M, Rosell R, Guillem V, Díaz-Rubio E, Moreno I, Soriano V, Fernández A, Pérez A. Martin M, et al. Eur J Cancer. 1993;29A Suppl 1:S33-4. doi: 10.1016/s0959-8049(05)80258-8. Eur J Cancer. 1993. PMID: 8427723 No abstract available.
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.
Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT, Albanell J, Aranda J, Munarriz B, Campbell J, Diaz-Rubio E; GEICAM Group (Spanish Breast Cancer Research Group), Spain. Martin M, et al. Ann Oncol. 2003 Jun;14(6):833-42. doi: 10.1093/annonc/mdg260. Ann Oncol. 2003. PMID: 12796019 Free article. Review.
12,808 results
You have reached the last available page of results. Please see the User Guide for more information.